Certified by Founder Lodge
Eikon Therapeutics
United States - Hayward, CA
START UP
1 Disclosed Funding Rounds $500,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threateni
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 06 ,2022 | Series B | $500,000,000 | |
| February, 27 ,2025 | Series D | $350,007,000.00 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
